IRCT2017012827311N2 IRCT 2017-02-10 Tabriz University of Medical Sciences The effect of oral Mullein capsules on the treatment of uterine leiomyomas. The effect of oral Mullein capsules (Verbascum Sp) on uterine leiomyomas size and the amount of menstrual bleeding in women with asymptomatic leiomyomas : a triple blind randomised controlled trial. 2017-02-19 anticipated 50 Complete https://irct.ir/trial/22401 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Assignment Sequence was determined using Random Computer Software (Random Allocation Software) through blocks 4 and 6 with a one to one assignment ratio. To conceal the allocation of capsules containing drugs and medicines, they were placed in the same packets of a matt burst numbered. Envelopes are numbered from 1 to 50. Sequencing and preparation of packets numbered by the person not involved in the collection and analysis of data was carried out, Blinding description: To conceal the allocation of capsules containing drugs and medicines, they were placed in the same packets of a matt burst numbered. Envelopes are numbered from 1 to 50. Sequencing and preparation of packets numbered by the person not involved in the collection and analysis of data was carried out. . In this study, the participants, the researcher and the person who examined the outcome (radiologist) were blinded to the intervention assigned to the participants. N/A Uterine leiomyomas. Intervention 1: The women in Intervention group will receive 400 mg oral mullein capsules twice a day for two months. Intervention 2: women in control group will receive 400 mg placebo capsules (containing flour) twice a day for two months. No - There is not a plan to make this available Justification or reason for not sharing IPD is No more information